References
- Ferrari C, Paracchi A, Mattei A M, De Vincentis S, D'Alberton A, Crosignami P G. Cabergoline in the long-term therapy of hyperprolactinemic disorders. Acta Endocrinol 1992; 126: 489–494
- Rains C P, Bryson H M, Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolac-tinaemia and inhibition of lactation. Drugs 1995; 49: 255–279
- Andreotti A-C, Pianezzola E, Persiani S, Pacciarini M A, Strolin-Benedetti M, Pontirol A E. Pharmacokinetics, pharmacodynamics and tolerability of cabergoline, a prolactin lowering drug after administration of increasing oral doses (0. 5, 1.0 and 1.5 milligrams) in healthy male volunteers. J Clin Endocrinol Metab 1995; 80: 841–845
- Benedetti M S, Dostert P, Barone D, Ethymiopoulos C, Peretti G, Roncucci R. In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine. Eur J Pharmacol 1990; 187: 399–408
- Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, Kurisu K. Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: In vitro culture studies. Endocrine J 1995; 42: 413–420
- Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, Kurisu K. In vitro effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors. Endocrine J 1995; 42: 153–161
- Mori H, Arakawa S, Ohkawa T, Ohkawa R, Takada S, Morita T, Okinaga S. The involvement of dopamine in the regulation of steroidogenesis in rat ovarian cells. Hormone Res 1994; 41((Suppl 1))36–40
- Hsueh AJ W, Wang C, Erickson G F. Direct inhibitory effect of gonadotropin-releasing hormone upon follicle-stimulating hormone induction of luteinizing hormone receptor and aromatase activity in rat granulosa cells. Endocrinology 1980; 106: 1697–1705
- Post K, Evans L E, Jüchle W. Effect of prolactin suppression with cabergoline in the pregnancy of the bitch. Theriogenolgy 1988; 29: 1233–1243
- Verstegen J P, Onclin K, Silva LD M, Donnay I. Abortion induced in the cat using prostaglandin F2α and a new anti-prolactinic agent cabergoline. J Reprod Fert Suppl 1993; 47: 411–417
- Rothchild I. The regulation of the mammalian corpus luteum. Recent Prog Horm Res 1981; 37: 183–283
- Onclin K, Silva LD M, Donnay I, Verstegen J P. Luteotropic action of pro-lactin in dogs and the effect of a dopamine agonist cabergoline. J Reprod Fert Suppl 1993; 47: 403–409
- Willis D, Mason H, Gilling-Smith C, Frank S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granu-losa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996; 81: 302–309
- Christenson L K, Stouffer R L. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J Clin Endocrinol Metab 1997; 82: 2135–2142
- Negishi H, Koide S S. Prevention and termination of pregnancy in the rat with cabergoline a dopamine agonist. J Reprod Fertil 1997; 109: 103–107
- Dorrington J, Gore-Langton R E. Prolactin inhibits oestrogen synthesis in the ovary. Nature 1981; 290: 600–602
- Wang C, Chan V. Divergent effects of prolactin on estrogen and progesterone production by granulosa cells of rat Graafian follicles. Endocrinology 1982; 110: 1085–1093
- Dorrington J, Gore-Langton R E. Antigonadal action of prolactin: further studies on the mechanism of inhibition of follicle-stimulating hormone-induced aromatase activity in rat granulosa cell cultures. Endocrinology 1982; 110: 1701–1707
- Krasnow J S, Hickey G J, Richard J S. Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol Endocrinol 1990; 4: 13–21
- Bodis J, Tinneberg H R, Török A, Cledon P, Hanf V, Papenfuss F. Effect of noradrenaline and dopamine on progesterone and estradiol secretion of human granulosa cells. Acta Endocrinol 1993; 129: 165–168
- Piomelli D, Pilon C, Ginos B, Sokoloff P, Matres M P, Schwartz J C. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 1991; 353: 164–167
- Arakawa S, Yago N, Isobe S, Ohkawa R, Mori H, Okinaga S. Dopamine increases the ovarian progesterone synthesis of PMSG-treated rats by regulating 17β-hydroxysteroid dehydrogenase activity. Folia Endocrinol Japonica 1994; 70: 447–456
- Ogawa N. Molecular and chemical neuropharmacology of dopamine receptor subtypes. Acta Med Okayama 1995; 49: 1–11